Presenters at “Looking Ahead to Kinase Inhibition in Rheumatoid Arthritis,” a session here at the 2011 ACR/ARHP Annual Scientific Meeting, delved into some of the big questions that rheumatology faces with kinase inhibitor use.
Search results for: Biologics
A Passion for Multidisciplinary Collaboration
Through teamwork, David T. Felson, MD, MPH, has advanced understanding and treatment of rheumatic diseases
A Short History of Rheumatoid Arthritis Therapeutics
Or, why I chose to become a rheumatologist
Opening a New Therapeutic Window for Rheumatoid Arthritis
New targets in rheumatoid arthritis: SYK, JAK, BTK
Clinical Trials Go Global
As medical research expands to the global population, will trial results sill apply to U.S. populations?
A&R and AC&R Abstracts: Pain in RA
For further reading
Rheumatologists Struggle with Drug Shortages
While not yet at a ‘catastrophic’ level, shortages are becoming more common
Thoughts after a Broken Ankle
A forced convalescence leads to insights into rheumatology and medicine
Drug Updates
Information on New Approvals and Medication Safety
Immunosuppressive Treatment for Lupus in the Next Decade
It’s time for a new strategy
- « Previous Page
- 1
- …
- 67
- 68
- 69
- 70
- 71
- …
- 75
- Next Page »